InMode (INMD) Change in Receivables (2018 - 2026)
InMode (INMD) posted quarterly Change in Receivables of $72000.0 for Q1 2026, down 98.42% year-on-year from $4.5 million in Q1 2025, and up 101.13% on a QoQ basis from -$6.4 million in Q4 2025.
InMode (INMD) Change in Receivables (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Change in Receivables for 9 consecutive years, with $72000.0 the latest figure, recorded in Q1 2026.
- Quarterly Change in Receivables fell 98.42% year-over-year to $72000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.9 million (down 1106.24% YoY) and the FY2025 annual result came in at -$7.5 million, down 225.26% from the prior year.
- Change in Receivables improved to $72000.0 in Q1 2026 per INMD's latest filing, from -$6.4 million in the prior quarter.
- Over the last five years, Change in Receivables for INMD reached as high as $9.3 million in Q1 2024 and fell as low as -$10.8 million in Q3 2023.
- A 5-year average of -$1.6 million and a median of -$2.4 million in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables surged 967.64% — and 2025, when it slumped 257.96%.
- Year by year, Change in Receivables stood at $805000.0 in 2022, then sank by 53.17% to $377000.0 in 2023, then jumped by 967.64% to $4.0 million in 2024, then sank by 257.96% to -$6.4 million in 2025, then jumped by 101.13% to $72000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $72000.0, -$6.4 million, and -$2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 72,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72,000.00 |
| Mar 31, 2026 | 72,000.00 |
| Dec 31, 2025 | -6.36 Mn |
| Dec 31, 2025 | -6.36 Mn |
| Sep 30, 2025 | -2.35 Mn |
| Sep 30, 2025 | -2.35 Mn |
| Jun 30, 2025 | -3.29 Mn |
| Jun 30, 2025 | -3.29 Mn |
| Mar 31, 2025 | 4.54 Mn |
| Mar 31, 2025 | 4.54 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Sep 30, 2024 | -2.57 Mn |
| Sep 30, 2024 | -2.57 Mn |
| Jun 30, 2024 | -4.81 Mn |
| Jun 30, 2024 | -4.81 Mn |
| Mar 31, 2024 | 9.31 Mn |
| Mar 31, 2024 | 9.31 Mn |
| Dec 31, 2023 | 377,000.00 |
| Dec 31, 2023 | 377,000.00 |